A set of ~800 largely isogenic deficiency stocks created by FLP-induced recombination between FRT-carrying transgenic insertions; molecularly defined deletion endpoints correspond to initial location of the progenitor insertions. Designed to fill gaps in deletion coverage and breakpoint placement; also used to replace older available deficiencies that have not been molecularly mapped.
Df(1)BSC843 is rescued by Dp(1;Y)y261l.
Inferred to overlap with: Dp(1;Y)y261l.
The presence of P+PBac{XP5.WH5}BSC843 was verified using the PCR methods and primers described in FBrf0175003.
Exelixis, Inc. determined the insertion site of the progenitor P{XP}d11753 to be Release 3 genomic coordinate 92123 on the X chromosome, which corresponds to Release 5 coordinate X:228718 . The insertion site of the progenitor PBac{WH}cinf05298 is Release 5 genomic coordinate 149001..149310 on the X chromosome. Consequently, the breakpoints of Df(1)BSC843 predicted from the Release 5 genomic coordinates of the progenitor transposable element insertion sites are X:149001..149310 ;228718 and the cytological breakpoints predicted from these coordinates are 1A1;1A3.